HomeHOFBF • OTCMKTS
add
Hofseth Biocare ASA
Market news
Financials
Income Statement
Revenue
Net income
| (NOK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 60.86M | 16.24% |
Operating expense | 49.86M | -2.65% |
Net income | -33.12M | -14.16% |
Net profit margin | -54.41 | 1.79% |
Earnings per share | — | — |
EBITDA | -22.96M | -41.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (NOK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.95M | 224.75% |
Total assets | 382.47M | -2.11% |
Total liabilities | 356.23M | 51.56% |
Total equity | 26.24M | — |
Shares outstanding | 411.08M | — |
Price to book | 2.21 | — |
Return on assets | -18.33% | — |
Return on capital | -26.86% | — |
Cash Flow
Net change in cash
| (NOK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -33.12M | -14.16% |
Cash from operations | -13.25M | 31.95% |
Cash from investing | -2.48M | -50.15% |
Cash from financing | 62.10M | 220.39% |
Net change in cash | 46.37M | 2,772.68% |
Free cash flow | -5.76M | 61.38% |
About
Founded
2000
Website
Employees
75
